Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Fulcrum Therapeutics, Inc. See All Filings	D	2020-06-10 17:47:13 UTC
Amount To Be Raised $68,499,987 Associated Brokers / Dealers SVB Leerink LLC CIK Number 0001680581 Filed Document 0001680581-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-06-10 17:47:13 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Fulcrum Therapeutics, Inc. See All Filings	D	2018-09-05 12:32:21 UTC
Amount To Be Raised $80,000,000 Associated Brokers / Dealers N/A CIK Number 0001680581 Filed Document 0001680581-18-000002 Exclusions or Exemptions 506b Accepted Date 2018-09-05 12:32:21 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Fulcrum Therapeutics, Inc. See All Filings	D/A	2017-07-25 09:27:39 UTC
Amount To Be Raised $55,000,000 Associated Brokers / Dealers N/A CIK Number 0001680581 Filed Document 0001680581-17-000002 Exclusions or Exemptions 506b Accepted Date 2017-07-25 09:27:39 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Fulcrum Therapeutics, Inc. See All Filings	D	2017-05-10 10:07:41 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers N/A CIK Number 0001680581 Filed Document 0001680581-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-05-10 10:07:41 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Fulcrum Therapeutics, Inc. See All Filings	D	2016-07-25 09:42:12 UTC
Amount To Be Raised $55,000,000 Associated Brokers / Dealers N/A CIK Number 0001680581 Filed Document 0001680581-16-000001 Exclusions or Exemptions 506b Accepted Date 2016-07-25 09:42:12 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity